Mazdutide
Innovative GLP-1/glucagon dual agonist for weight loss, glycemic control, and metabolic disease treatment.
$120.00 / unit
1
Total:$120.00
GMP Compliant≥99% PurityGlobal Shipping
Mazdutide (MAZ5/MAZ10) is a novel GLP-1/glucagon receptor dual agonist that promotes weight loss through appetite suppression and increased energy expenditure. It represents the next generation of dual-pathway obesity therapeutics.
Key Benefits
- Dual mechanism: appetite suppression + increased energy expenditure
- Significant weight loss with improved body composition
- Improves glycemic control and insulin sensitivity
- May improve lipid profiles and liver fat
- Once-weekly subcutaneous dosing
Reconstitution Instructions
- Reconstitute with Bacteriostatic Water (BAC)
- Gently swirl until fully dissolved
- Refrigerate after reconstitution (2–8°C)
Dosing Guidelines
- Start at low dose, titrate upward per protocol
- Once-weekly subcutaneous injection
- Therapeutic range per research protocol
Product Note
Mazdutide is part of the new wave of dual incretin/glucagon agonists for metabolic disease research.